- Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition
Sally A. Fahim et al, 2024, Scientific Reports CrossRef - The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review
Kai Liu et al, 2020, Cancer Cell International CrossRef - Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies
Abdulrahim A. Alzain et al, 2024, Frontiers in Chemistry CrossRef - Prolyl isomerase Pin1: a promoter of cancer and a target for therapy
Yang Chen et al, 2018, Cell Death & Disease CrossRef - Proteomics Approaches for the Discovery of Potential Enzymatic Biomarkers for Early Diagnosis of Breast Cancer
Yingxi Li et al, 2023, The 2nd International Electronic Conference on Biomedicines CrossRef